The Romanian drug manufacturer Biofarm (stock symbol BIO) reached in 2020 a turnover of 218 million lei, 8% higher compared to 2019. At the same time, the EBITDA level of the company registered an increase of 9%, reaching the value of 75 million lei.
For more information, please see the Romanian version of the article, here.